Nina SAS made an offer to acquire the remaining 70.6% stake in Euromedis Groupe (ENXTPA:EMG) for €14.8 million on December 6, 2016. As per terms, Nina SAS made an offer of €7.01 per share to the remaining shareholders. The completion of the offer will be subject to the approval of the Autorité de la concurrence. An independent expert will be appointed in order to decide on the fairness of the price to be offered in the offer. As of January 22, 2017, the deal has been approved by the French stock market regulator AMF. As on February 24, 2016, 0.78 million Euromedis shares were tendered to Nina SAS. Following which, Nina SAS owns 1.78 million Euromedis shares representing 55.38% stake in Euromedis. The required minimal condition of Nina acquiring Euromedis shares representing 50% stake being satisfied, the offer is deemed successful. The offer will be reopened shortly, in accordance with the regulation, to offer a second chance to shareholders to tender their securities. Nina, however does not intend to delist Euromedis after the offer. As of March 1, 2017, the settlement-delivery is scheduled on March 3, 2017. As a result of the acquisition, Roturier family would own 0.82 million shares and 27.71% of the capital, Nina would own 1.65 million shares and 55.38% of the capital, Public and other investors would own 0.48 million shares and 16.06% of the capital and Treasury 0.02 million shares and 0.85% of the capital. The offer will be reopened at the same price of €7.01 per Euromedis Groupe share from March 6 to March 17, 2017 included.